ECRON ACUNOVA

Centerwatch

Events

Dr Kohkan Shamsi speaking at the 4th Medical Imaging Conference in Washington

Dr Kohkan Shamsi, MD, PhD, a member of the Board of Diretors of AcuNova Life Science Ltd, UK and a Scientific Advisor to the company, will be addressing the 4th Medical Imaging Conference in Washington. The event is scheduled on Oct 26-27, 2006. Leverage Medical Imaging as a Clinical Decision Making Tool and Apply Imaging Standards to Support FDA Submissions

Dr Shamsi will be speaking on Oct 26 at 11:15 am. He will focus on 'Reviewing New Imaging Contrast Agents and Tracers'. Venue: Tysons Corner, VA

Topic summary : Review New Imaging Contrast Agents and Tracers

The role of imaging methodologies, contrast agents and tracers in clinical trials is continuously increasing. Therefore it is very important to understand the characteristics, advantages and limitations of imaging modalities and contrast agents before making a decision to use them in clinical trials.

Learn the contrast agents for CT, MRI and nuclear medicine
Hear about safety issues related to contrast agents used in clinical trials
Discover the advantages and limitations of current imaging modalities used in clinical trials
Know how to choose an imaging modality and contrast agent in a specific clinical trial
Recognize common problems and solutions when using medical imaging in clinical trials

About Dr Kohkan Shamsi, M.D., Ph.D.

Dr. Shamsi brings extensive experience in Drug Development of dignostic agents and Bio-imaging markers in clinical trials. He has worked in leadership positions in Diagnostic Imaging Strategic Business Unit at Schering AG, Berlin, Germany and in the Diagnostic Imaging and Radiopharmaceuticals Business Unit, Clinical Operations and medical development at Berlex Inc., NJ, USA. He has launched several products and has been a thought leader with FDA and EU regulators in the last decade.. He has mentored the development of imaging-CRO's (I-CRO) in this emerging field. Dr. Shamsi is an MD in Radiodiagnosis from Aligarh Muslim University and a Ph.D from the University of Antwerp, Belgium. Dr. Shamsi has published over 90 papers in indexed journals. Dr. Shamsi has conceptualized, coordinated, and executed over 25 multi-center, international clinical trials (phase I - phase III) to develop new contrast agents for oncology imaging, CNS, Magnetic Resonance Angiography and cardiac imaging. He has also submitted many NDAs in Europe, USA and Japan. Dr. Shamsi is a member of Radiological Society of North America and International Society of Magnetic Resonance in Medicine. He is also a member of North American Society of Cardiac Imaging and Indian Radiology & Imaging Association.

For any queries/ appointments, please email:

Kohkan.shamsi@acunovalife.com
Michael.kokesh@acunovalife.com
murali.mohan@acunovalife.com